These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19481639)

  • 21. Current developments in and importance of high-performance computing in drug discovery.
    Pitera JW
    Curr Opin Drug Discov Devel; 2009 May; 12(3):388-96. PubMed ID: 19396740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging field of chemical genetics: potential applications for pesticide discovery.
    Walsh TA
    Pest Manag Sci; 2007 Dec; 63(12):1165-71. PubMed ID: 17912687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanding medicinal chemistry space.
    Barker A; Kettle JG; Nowak T; Pease JE
    Drug Discov Today; 2013 Mar; 18(5-6):298-304. PubMed ID: 23117010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping human metabolic pathways in the small molecule chemical space.
    Macchiarulo A; Thornton JM; Nobeli I
    J Chem Inf Model; 2009 Oct; 49(10):2272-89. PubMed ID: 19795883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative investigation of the chemical space surrounding amino acid alphabet formation.
    Lu Y; Freeland SJ
    J Theor Biol; 2008 Jan; 250(2):349-61. PubMed ID: 18005995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open Innovation Drug Discovery (OIDD): a potential path to novel therapeutic chemical space.
    Alvim-Gaston M; Grese T; Mahoui A; Palkowitz AD; Pineiro-Nunez M; Watson I
    Curr Top Med Chem; 2014; 14(3):294-303. PubMed ID: 24283973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered protein scaffolds as next-generation antibody therapeutics.
    Gebauer M; Skerra A
    Curr Opin Chem Biol; 2009 Jun; 13(3):245-55. PubMed ID: 19501012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to achieve confidence in drug discovery and development: managing risk (from a reductionist to a holistic approach).
    Bakker A; Caricasole A; Gaviraghi G; Pollio G; Robertson G; Terstappen GC; Salerno M; Tunici P
    ChemMedChem; 2009 Jun; 4(6):923-33. PubMed ID: 19434656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Searching for recursively defined generic chemical patterns in nonenumerated fragment spaces.
    Ehrlich HC; Henzler AM; Rarey M
    J Chem Inf Model; 2013 Jul; 53(7):1676-88. PubMed ID: 23751070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solving chemical problems through the application of evolutionary principles.
    Rozenman MM; McNaughton BR; Liu DR
    Curr Opin Chem Biol; 2007 Jun; 11(3):259-68. PubMed ID: 17548235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The exploration of macrocycles for drug discovery--an underexploited structural class.
    Driggers EM; Hale SP; Lee J; Terrett NK
    Nat Rev Drug Discov; 2008 Jul; 7(7):608-24. PubMed ID: 18591981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Where is the hope for drug discovery? Let history tell the future.
    Kong DX; Li XJ; Zhang HY
    Drug Discov Today; 2009 Feb; 14(3-4):115-9. PubMed ID: 18687410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of natural products upon modern drug discovery.
    Ganesan A
    Curr Opin Chem Biol; 2008 Jun; 12(3):306-17. PubMed ID: 18423384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of power-laws in chemical space.
    Benz RW; Swamidass SJ; Baldi P
    J Chem Inf Model; 2008 Jun; 48(6):1138-51. PubMed ID: 18522387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-like properties: guiding principles for the design of natural product libraries.
    Camp D; Davis RA; Campitelli M; Ebdon J; Quinn RJ
    J Nat Prod; 2012 Jan; 75(1):72-81. PubMed ID: 22204643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of new synthetic scaffolds using framework libraries selected and refined via medicinal chemist synthetic expertise.
    Webb TR; Venegas RE; Wang J; Deschenes A
    J Chem Inf Model; 2008 Apr; 48(4):882-8. PubMed ID: 18335978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definition and detection of outliers in chemical space.
    Casalegno M; Sello G; Benfenati E
    J Chem Inf Model; 2008 Aug; 48(8):1592-601. PubMed ID: 18652445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand efficiency and fragment-based drug discovery.
    Bembenek SD; Tounge BA; Reynolds CH
    Drug Discov Today; 2009 Mar; 14(5-6):278-83. PubMed ID: 19073276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.